Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial

PURPOSE: Opioid-free anaesthesia (OFA) is increasingly used to limit intraoperative opioids in oncological surgery, but evidence in radical prostatectomy is scarce. We compared OFA with a remifentanil-based technique in laparoscopic radical prostatectomy (LRP) on a uniform multimodal and regional analgesic background. METHODS: Adult men undergoing LRP were randomized to OFA (dexmedetomidine plus ketamine, no intraoperative opioids) or a remifentanil-based technique. Both groups received identical multimodal premedication, bilateral quadratus lumborum block, sevoflurane maintenance and identical oxycodone patient-controlled analgesia (PCA). The primary outcome was total oxycodone consumption over the first 24 postoperative hours. Pre-specified secondary outcomes included Numeric Rating Scale (NRS) pain scores, postoperative nausea and vomiting (PONV), serum creatinine change to day 1, and the demanded-to-delivered PCA bolus ratio. RESULTS: Fifty-seven patients were analysed (OFA n = 32; remifentanil n = 25). Total 24-h oxycodone consumption did not differ (location-shift estimate - 2.0 mg, 95% CI -8.0 to 6.0; p = 0.556), and neither NRS scores nor PONV differed significantly. The demanded-to-delivered PCA bolus ratio was lower with OFA (location-shift estimate - 0.20, 95% CI -0.267 to 0.000; p = 0.006), as was the early rise in serum creatinine (location-shift estimate - 7.7 µmol/L, 95% CI -13.9 to -1.1; p = 0.034). Intraoperative bradycardia and hypotension did not differ significantly. CONCLUSION: In LRP, no statistically significant difference in 24-hour oxycodone consumption or pain scores was detected between OFA and remifentanil-based anaesthesia. The trial was not designed or powered for equivalence or non-inferiority, and these findings therefore do not establish comparable efficacy. Differences in two pre-specified secondary outcomes (a lower demanded-to-delivered PCA ratio and a smaller early creatinine rise) are hypothesis-generating. Because recruitment was curtailed, findings require confirmation in adequately powered trials, ideally in robot-assisted prostatectomy. TRIAL REGISTRATION: ClinicalTrials.gov NCT06380244, registered 23 April 2024.

Authors

Institutions

Publication Details

Journal
World Journal of Urology
Published
2026-11-17
DOI
https://doi.org/10.1007/s00345-026-06923-y
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial

Wojciech Szpunar, Anna Kwinta, Tomasz Drygalski, Jan Szpor et al.
3 links
World Journal of Urology
Anesthesia and Pain Management
article

Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial

Wojciech Szpunar, Anna Kwinta, Tomasz Drygalski, Jan Szpor, Tomasz Składzień, Michał Cicio, Katarzyna Maciejewska, Maciejewski Pawel, Tomasz Lonc, Tomasz Klimczyk, Aleksandra Żmuda, Renata Bugielska
article en

Abstract

PURPOSE: Opioid-free anaesthesia (OFA) is increasingly used to limit intraoperative opioids in oncological surgery, but evidence in radical prostatectomy is scarce. We compared OFA with a remifentanil-based technique in laparoscopic radical prostatectomy (LRP) on a uniform multimodal and regional analgesic background. METHODS: Adult men undergoing LRP were randomized to OFA (dexmedetomidine plus ketamine, no intraoperative opioids) or a remifentanil-based technique. Both groups received identical multimodal premedication, bilateral quadratus lumborum block, sevoflurane maintenance and identical oxycodone patient-controlled analgesia (PCA). The primary outcome was total oxycodone consumption over the first 24 postoperative hours. Pre-specified secondary outcomes included Numeric Rating Scale (NRS) pain scores, postoperative nausea and vomiting (PONV), serum creatinine change to day 1, and the demanded-to-delivered PCA bolus ratio. RESULTS: Fifty-seven patients were analysed (OFA n = 32; remifentanil n = 25). Total 24-h oxycodone consumption did not differ (location-shift estimate - 2.0 mg, 95% CI -8.0 to 6.0; p = 0.556), and neither NRS scores nor PONV differed significantly. The demanded-to-delivered PCA bolus ratio was lower with OFA (location-shift estimate - 0.20, 95% CI -0.267 to 0.000; p = 0.006), as was the early rise in serum creatinine (location-shift estimate - 7.7 µmol/L, 95% CI -13.9 to -1.1; p = 0.034). Intraoperative bradycardia and hypotension did not differ significantly. CONCLUSION: In LRP, no statistically significant difference in 24-hour oxycodone consumption or pain scores was detected between OFA and remifentanil-based anaesthesia. The trial was not designed or powered for equivalence or non-inferiority, and these findings therefore do not establish comparable efficacy. Differences in two pre-specified secondary outcomes (a lower demanded-to-delivered PCA ratio and a smaller early creatinine rise) are hypothesis-generating. Because recruitment was curtailed, findings require confirmation in adequately powered trials, ideally in robot-assisted prostatectomy. TRIAL REGISTRATION: ClinicalTrials.gov NCT06380244, registered 23 April 2024.

World Journal of UrologyVol. 44(1)
Jagiellonian University (PL)
Good health and well-being
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon